NCT03588572View on ClinicalTrials.gov

The Effect of Venlafaxine on Language Function in Patients With Subcortical Aphasia: A fMRI Study

NACompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

August 1, 2018

Primary Completion Date

July 1, 2019

Study Completion Date

August 1, 2019

Conditions
Subcortical AphasiaIschemic Stroke
Interventions
DRUG

Venlafaxine hydrochloride capsules

The patients in venlafaxine group begin to take the venlafaxine hydrochloride capsules after the first visitation(the first day after randomization), each containing venlafaxine 75mg, 1 capsule per day, until 4 weeks after randomization

Trial Locations (2)

510000

Guangzhou General Hospital of Guangzhou Military Command, Guangzhou

510010

Cerebrovascular Department of General Hospital of Guangzhou Military Command of PLA, Guangzhou

All Listed Sponsors
lead

Guangzhou General Hospital of Guangzhou Military Command

OTHER

NCT03588572 - The Effect of Venlafaxine on Language Function in Patients With Subcortical Aphasia: A fMRI Study | Biotech Hunter | Biotech Hunter